Evidence map›Paper›PMID 33627648›Full record

ArticleNature communications2021

Loss of NPC1 enhances phagocytic uptake and impairs lipid trafficking in microglia.

Alessio Colombo, Lina Dinkel, Stephan A Müller, Laura Sebastian Monasor, Martina Schifferer, Ludovico Cantuti-Castelvetri, Jasmin König, Lea Vidatic, Tatiana Bremova-Ertl, Andrew P Lieberman and 6 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed, 1 pooled it
10.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 1 synthesis or guideline pooled it, 104 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. SLC16A6 is a tyrosine transporter for the melanosome.bioRxiv : the preprint server for biology · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 4 countries.

Alessio Colombo *German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.
Lina Dinkel *German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.
Stephan A MüllerGerman Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.ORCID http://orcid.org/0000-0003-3414-307X
Laura Sebastian MonasorGerman Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.
Martina SchiffererMunich Cluster for Systems Neurology (SyNergy), Munich, Germany.ORCID http://orcid.org/0000-0002-0500-8218
Ludovico Cantuti-CastelvetriGerman Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-0642-1610
Jasmin KönigGerman Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.
Lea VidaticDivision of Molecular Medicine, Ruder Boskovic Institute, Zagreb, Croatia.
Tatiana Bremova-ErtlDepartment of Neurology, Ludwig-Maximilians University, Munich, Germany.
Andrew P LiebermanDepartment of Pathology, University of Michigan, Ann Arbor, MI, USA.
Silva HecimovicDivision of Molecular Medicine, Ruder Boskovic Institute, Zagreb, Croatia.
Mikael SimonsGerman Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.
Stefan F LichtenthalerGerman Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.
Michael StruppDepartment of Neurology, Ludwig-Maximilians University, Munich, Germany.
Susanne A SchneiderDepartment of Neurology, Ludwig-Maximilians University, Munich, Germany.
Sabina TahirovicGerman Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany. Sabina.Tahirovic@dzne.de.ORCID http://orcid.org/0000-0003-4403-9559
German Center for Neurodegenerative Diseases · DELudwig-Maximilians-Universität München · DERuđer Bošković Institute · HRMunich Cluster for Systems Neurology · DEUniversity Hospital of Bern · CHUniversity of Michigan · US

Funding

Michigan Alzheimer's Disease Core CenterP30AG053760 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LIEBERMAN, ANDREW P · 2016 to 2020
$10.1M
Unraveling mechanisms of Niemann-Pick C neuropathology with mouse modelsR01NS063967 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LIEBERMAN, ANDREW P · 2009 to 2020
$4.4M
NIA NIH HHS P30 AG053760NINDS NIH HHS R01 NS063967
6 · The paper itself

Abstract

Niemann-Pick type C disease is a rare neurodegenerative disorder mainly caused by mutations in NPC1, resulting in abnormal late endosomal/lysosomal lipid storage. Although microgliosis is a prominent pathological feature, direct consequences of NPC1 loss on microglial function remain not fully characterized. We discovered pathological proteomic signatures and phenotypes in NPC1-deficient murine models and demonstrate a cell autonomous function of NPC1 in microglia. Loss of NPC1 triggers enhanced phagocytic uptake and impaired myelin turnover in microglia that precede neuronal death. Npc1

Indexed as

AnimalsBlotting, WesternCells, CulturedCholesterolFemaleHumansIntracellular Signaling Peptides and ProteinsMaleMass SpectrometryMiceMice, Inbred C57BLMice, KnockoutMicrogliaMyelin SheathNiemann-Pick C1 ProteinNiemann-Pick Disease, Type CCholesterolIntracellular Signaling Peptides and ProteinsNiemann-Pick C1 ProteinNpc1 protein, mouse

Identifiers

PMID33627648
PMCPMC7904859
OpenAlexW3131202669

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.